---
layout: startup_page
title: "NextPoint Therapeutics"
id: "nextpointtx.com"
permalink: "/nextpointtherapeuticsnextpointtx.com04272025/"
website: "https://nextpointtx.com/"
funding_round: "Series B"
funding_amount: "$122.5M"
investors: "Catalio Capital Management, MPM BioImpact, Leaps by Bayer, Sanofi Ventures, Invus, Sixty Degree Capital, Dana-Farber Cancer Instituteâ€™s Binney Street Capital, Gordon Freeman, Arkin Bio-Capital, WTT investment Ltd"
about: "NextPoint Therapeutics is a clinical-stage biotechnology company developing precision oncology therapeutics targeting the HHLA2 pathway. Their innovative approach integrates foundational science with a defined clinical biomarker strategy to deliver a new class of monotherapies. The company is advancing multiple assets into clinical trials to exploit HHLA2's role in both immune checkpoint and tumor-targeting."
markets: "Biotechnology, Oncology, Immuno-oncology, Health Care, Life Science, Therapeutics"
hq: "Cambridge, Massachusetts, United States"
founded_year: "2020"
linkedin: "https://www.linkedin.com/company/nextpoint-therapeutics"
twitter: "https://twitter.com/NextPointTX"
instagram: ""
facebook: ""
crunchbase: "https://www.crunchbase.com/organization/nextpoint-therapeutics"
pitchbook: ""

# SEO Optimization
meta_title: "NextPoint Therapeutics - Series B Funding ($122.5M)"
meta_description: "NextPoint Therapeutics, NextPoint Therapeutics is a clinical-stage biotechnology company developing precision oncology therapeutics targeting the HHLA2 pathway. Their innovat..."
meta_keywords: "NextPoint Therapeutics, Biotechnology, Oncology, Immuno-oncology, Health Care, Life Science, Therapeutics, Series B funding"
canonical_url: "https://pkprojectstartups.github.io/projectstartups.com/nextpointtherapeuticsnextpointtx.com04272025/"
---